Head/Neck Cancer

Top Story

FDA places clinical hold on trial of axalimogene filolisbac and durvalumab after patient death

March 13, 2018
Meeting News

Treatment of recurrent or metastatic head and neck cancer remains challenging

March 9, 2018
NEW YORK — Treatment of recurrent or metastatic head and neck cancer is challenging given the availability of only a few treatment options, according to a…

Molecular testing for thyroid cancer can reduce unnecessary surgeries

March 9, 2018
Most thyroid nodules are benign, and cytologic specimens collected through fine-needle aspiration can usually be diagnosed as malignant or benign based on their…
In the Journals Plus

Extra-thyroid extension increases recurrence rates in differentiated thyroid cancer

March 5, 2018
Extra-thyroid extension increases the risk for disease recurrence in adults with differentiated thyroid cancer compared with those without extension, but overall…
More Headlines »

Ace the Case: A 54-Year-Old Man With Intermittent, Painless Hematuria for the Past 4 Weeks

There is no commercial support for this activity.

This “Ace the Case” study will discuss the treatment of a 54-year-old man who presents with intermittent…
More »
Meeting News Coverage

VIDEO: Less surgery, active surveillance viable option for low-risk thyroid cancer

September 22, 2016
More »
Resource Centers
HemOnc Today New York

HemOnc Today New York


EGFR-mutated NSCLC: Differentiating Options to Optimize Patient Care

This educational activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Lung cancer is the second most commonly diagnosed cancer within the United States and accounts for approximately 25% of…
More »